Primary Spinal Astrocytomas: A Literature Review
- PMID: 31565645
- PMCID: PMC6759039
- DOI: 10.7759/cureus.5247
Primary Spinal Astrocytomas: A Literature Review
Abstract
Primary spinal astrocytoma is a subtype of glioma, the most common spinal cord tumor found in the intradural intramedullary compartment. Spinal astrocytomas account for 6-8% of all spinal cord tumors and are primarily low grade (World Health Organization grade I (WHO I) or WHO II). They are seen in both the adult and pediatric population with the most common presenting symptoms being back pain, sensory dysfunction, or motor dysfunction. Magnetic Resonance Imaging (MRI) with and without gadolinium is the imaging of choice, which usually reveals a hypointense T1 weighted and hyperintense T2 weighted lesion with a heterogeneous pattern of contrast enhancement. Further imaging which may aid in surgical planning includes computerized tomography, diffusion tensor imaging, and tractography. Median survival in spinal cord astrocytomas ranges widely. The factors most significantly associated with poor prognosis and shorter median survival are older age at initial diagnosis, higher grade lesion based on histology, and extent of resection. The mainstay of treatment for primary spinal cord astrocytomas is surgical resection, with the goal of preservation of neurologic function, guided by intraoperative neuromonitoring. Adjunctive radiation has been shown beneficial and may increase overall survival. The role of adjunctive chemotherapy is employed, however, its benefit has not been clearly defined. Primary spinal cord astrocytomas are rare and challenging to treat. The gold standard treatment is surgical resection. Second-line treatments include radiation and chemotherapy, although, the optimal regimen for adjunctive therapy has not yet been clearly defined.
Keywords: astrocytoma; glioblastoma; glioma; intradural; intramedullary; spinal astrocytoma; spinal cord neoplasms; spinal tumor.
Copyright © 2019, Ogunlade et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Surgical outcomes of pediatric spinal cord astrocytomas: systematic review and meta-analysis.J Neurosurg Pediatr. 2018 Oct;22(4):404-410. doi: 10.3171/2018.4.PEDS17587. Epub 2018 Jul 20. J Neurosurg Pediatr. 2018. PMID: 30028275
-
Spinal cord astrocytomas: presentation, management and outcome.J Neurooncol. 2000 May;47(3):219-24. doi: 10.1023/a:1006466422143. J Neurooncol. 2000. PMID: 11016738 Review.
-
Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients.Neurosurgery. 2008 Jul;63(1):55-60; discussion 60-1. doi: 10.1227/01.NEU.0000335070.37943.09. Neurosurgery. 2008. PMID: 18728568
-
Astrocytomas of the spinal cord.Neurooncol Adv. 2024 Feb 13;6(Suppl 3):iii48-iii56. doi: 10.1093/noajnl/vdad166. eCollection 2024 Oct. Neurooncol Adv. 2024. PMID: 39430394 Free PMC article. Review.
-
[MRI symptomatology of primary intraspinal cord gliomas].J Neuroradiol. 1995 Mar;22(1):28-42. J Neuroradiol. 1995. PMID: 7707132 French.
Cited by
-
Surgical treatment and neurological outcome of infiltrating intramedullary astrocytoma WHO II-IV: a multicenter retrospective case series.J Neurooncol. 2021 Jan;151(2):181-191. doi: 10.1007/s11060-020-03647-w. Epub 2020 Oct 22. J Neurooncol. 2021. PMID: 33094355 Free PMC article.
-
Glioma Immunotherapy: Advances and Challenges for Spinal Cord Gliomas.Neurospine. 2022 Mar;19(1):13-29. doi: 10.14245/ns.2143210.605. Epub 2022 Feb 2. Neurospine. 2022. PMID: 35130421 Free PMC article.
-
Transcriptomic Portraits and Molecular Pathway Activation Features of Adult Spinal Intramedullary Astrocytomas.Front Oncol. 2022 Mar 21;12:837570. doi: 10.3389/fonc.2022.837570. eCollection 2022. Front Oncol. 2022. PMID: 35387112 Free PMC article.
-
Safety and Efficacy of Stereotactic Radiosurgery in the Management of Primary Spinal Cord Glioblastoma: A Case Report.Cancer Manag Res. 2025 Feb 19;17:349-355. doi: 10.2147/CMAR.S509635. eCollection 2025. Cancer Manag Res. 2025. PMID: 39990275 Free PMC article.
-
Advances in imaging modalities for spinal tumors.Neurooncol Adv. 2024 Apr 9;6(Suppl 3):iii13-iii27. doi: 10.1093/noajnl/vdae045. eCollection 2024 Oct. Neurooncol Adv. 2024. PMID: 39430391 Free PMC article. Review.
References
-
- Intramedullary spinal cord tumors: molecular insights and surgical innovation. Parsa AT, Chi JH, Acosta FL, Ames CP, McCormick PC. https://pdfs.semanticscholar.org/3670/0a3f1d0a6d5158c2b062b6d5be7617a88d.... Clin Neurosurg. 2005;52:76–84. - PubMed
-
- Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. Lonser RR, Weil RJ, Wanebo JE, Devroom HL, Oldfield EH. J Neurosurg. 2003;98:106–116. - PubMed
-
- Primary spinal cord glioma: a surveillance, epidemiology, and end results database study. Milano MT, Johnson MD, Sul J, Mohile NA, Korones DN, Okunieff P, Walter KA. J Neurooncol. 2010;98:83–92. - PubMed
-
- Intramedullary spinal cord tumors: a review of current and future treatment strategies. Tobin MK, Geraghty JR, Engelhard HH, Linninger AA, Mehta AI. Neurosurg Focus. 2015;39:14. - PubMed
-
- Prognosis and treatment of spinal cord astrocytoma. Minehan KJ, Brown PD, Scheithauer BW, Krauss WE, Wright MP. Int J Radiat Oncol Biol Phys. 2009;73:727–733. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical